Exenatide Once Weekly in the Treatment of Patients with Multiple System Atrophy

Overview of attention for article published in Annals of Neurology, July 2025

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news: 2 news outlets
twitter: 6 X users

bluesky: 4 Bluesky users

Readers on

mendeley: 21 Mendeley

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 97,123 followers.

RT @ScienceofPD: A single-center, randomized, open label trial assessing 48 weeks of exenatide in 50 participants with Multiple System Atro…

RT @NatRevNeurol: Exenatide Once Weekly in the Treatment of Patients with Multiple System Atrophy https://t.co/KmjaNlfeKY

A single-center, randomized, open label trial assessing 48 weeks of exenatide in 50 participants with Multiple System Atrophy (randomly assigned 1:1 to exenatide or control) reports a positive result (UMSARS parts I + II scores @ 48 weeks) https://t.co/ZK…

RT @NatRevNeurol: Exenatide Once Weekly in the Treatment of Patients with Multiple System Atrophy https://t.co/KmjaNlfeKY

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 2 additional X posts.